β2 adrenergic receptor 5′ haplotypes influence promoter activity
Open Access
- 1 December 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 137 (8) , 1213-1216
- https://doi.org/10.1038/sj.bjp.0704935
Abstract
Transcriptional control of the human β2 adrenergic receptor gene (ADRB2) predominantly resides within a 549 base pair region immediately 5′ to the start of translation. Within this region, four naturally occurring polymorphisms, −468 C→G, −367 T→C, −47 T→C, and −20 T→C, have been identified. To determine the individual site and haplotype effects of these polymorphisms, we generated 16 luciferase‐based mutant constructs which were transiently transfected into HEK293 cells, and measured ADRB2 promoter‐driven luciferase activity. Two of the 16 mutant constructs, GCCT (−468G, −367C, −47C, −20T) and CTCT, showed a highly significant 3 fold decrease in luciferase induction relative to the reference CTTT. These haplotype effects could not be accounted for by the separate and additive effects of each site. These findings indicate that promoter polymorphisms interact to significantly alter β2 adrenergic receptor expression, and should be examined further for their association with disease‐related phenotypes. British Journal of Pharmacology (2002) 137, 1213–1216. doi:10.1038/sj.bjp.0704935Keywords
This publication has 15 references indexed in Scilit:
- Vascular Adrenoceptors: An UpdatePharmacological Reviews, 2001
- Complex promoter and coding region β 2 -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsivenessProceedings of the National Academy of Sciences, 2000
- Positional Genomic Analysis Identifies the β 2 -Adrenergic Receptor Gene as a Susceptibility Locus for Human HypertensionCirculation, 2000
- Polymorphism in the 5′-Leader Cistron of theβ 2-Adrenergic Receptor Gene Associated with Obesity and Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 1999
- Polymorphism in the 5'-Leader Cistron of the 2-Adrenergic Receptor Gene Associated with Obesity and Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 1999
- Identification of novel polymorphisms within the promoter region of the human β2 adrenergic receptor geneBritish Journal of Pharmacology, 1999
- Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression.Journal of Clinical Investigation, 1998
- Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.Journal of Clinical Investigation, 1995
- Site-directed mutagenesis of virtually any plasmid by eliminating a unique siteAnalytical Biochemistry, 1992
- Molecular and cellular biology of adrenergic receptorsTrends in Cardiovascular Medicine, 1991